This month’s Synapse includes articles on:
- outsourcing the manufacture of drugs;
- reimbursement of biosimilars;
- UK tax relief for R&D; pensions — there is no alternative;
- why do we need data-protection policies?;
- R&D tax relief — the SME scheme;
- and R&D tax relief — the large company scheme.
If you are registered and logged in to the site, click on the link below to read the rest of the Taylor Wessing briefing. If not, please register or sign in with your details below.